Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese Participants

Study Identifier
M25-644
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Healthy Volunteer
  • Study Drug
  • ABBV-932
  • Placebo for ABBV-932
  • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18 - 55 Years

    Protocol Summary

    This study will assess the adverse events, tolerability, and how oral doses of ABBV-932 moves through the body in healthy adult Chinese participants.

    Study Locations

    Location
    Status
    Location
    Shanghai Mental Health Center /ID# 273427
    Shanghai, Shanghai Municipality, China, 200030
    Status
    Not applicable